High‐dose methylphenidate vs placebo
Hyperactivity · Children aged 6 to 18 years with ASD
1 finding from 1 review
- Methylphenidate for children and adolescents with autism spectrum disorder 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 71 participantsLow